Certified by Founder
Lodge
MAYD: MEDS AT YOUR DOORSTEP
start up
Germany
- Berlin
- 27/01/2022
- Series A
- $34,000,000
MAYD delivers meds to your doorstep in 30 minutes, free of charge, 365 days a year. We are building Europe’s first telepharmacy platform, offering over 3,000 healthcare-related goods in a more convenient, more supportive, and more consultative way. Backed by world-class investors with over $45M shortly after launch, our team consists of serial entrepreneurs and experienced operators who are passionate about helping people get their meds faster when they need them most.
Interested in joining us on our mission to make people’s lives a little bit healthier and easier? See all our job openings here: https://boards.eu.greenhouse.io/mayd
- Industry Pharmaceutical Manufacturing
- Website https://www.getmayd.com/en-de/
- LinkedIn https://www.linkedin.com/company/mayd-meds-at-your-doorstep/about/
Parhelia Biosciences | Undisclosed Amount | (Oct 18, 2023)
Cloover | $7,388,000 | (Oct 18, 2023)
Hallmark Health Care Solutions | Undisclosed Amount | (Oct 18, 2023)
Prove | $40,000,000 | (Oct 18, 2023)
Reality Defender | $15,000,000 | (Oct 18, 2023)
Yardstik | $12,000,000 | (Oct 18, 2023)
Nucleus RadioPharma | $56,000,000 | (Oct 18, 2023)
Society Brands | $25,000,000 | (Oct 18, 2023)
Nova Credit | $45,000,000 | (Oct 18, 2023)
Anonybit | $3,000,000 | (Oct 18, 2023)
Zelus Analytics | Undisclosed Amount | (Oct 18, 2023)
Scorability | $11,000,000 | (Oct 18, 2023)